Does the monthly cost stay the same throughout a protocol?

No. SURMOUNT-1's titration schedule escalates the dose roughly every four weeks, from 2.5 mg up to 15 mg, and each step consumes more milligrams per month than the last, so the monthly cost rises in the same six steps rather than staying flat.

How much does a full titration to the top dose cost in total?

Working through all six steps at this site's catalog price, the first five escalation months total about 1,500 dollars, and each month at the 15 mg maintenance dose after that adds about 600 dollars, for a first-year total near 5,700 dollars if a protocol reaches and holds the top dose.

Are there monthly costs beyond the vial itself?

Yes. Reconstitution water and injection supplies add a modest, largely fixed amount on top of the vial cost, since a single bottle of bacteriostatic water reconstitutes several vials and a pack of sterile needles covers roughly two months of once-weekly injections.

Is tirzepatide's monthly cost lower with insurance?

It can be dramatically lower when a plan covers it, sometimes a copay of a few dollars, but coverage is plan-specific and not guaranteed, especially for the obesity indication. The full route-by-route cost ranking, including LillyDirect's self-pay tiers, is in how to get tirzepatide cheaper.

How Much Does Tirzepatide Cost Per Month? A 2026 Budget Breakdown

Quick answer

Tirzepatide's monthly cost is not fixed. In the research-compound market, at this site's 10 mg vial price of 100 dollars, it runs from about 100 dollars a month at the 2.5 mg starting dose to about 600 dollars a month at the 15 mg top dose, because each titration step consumes more milligrams. ^[1]
A full escalation to the 15 mg maintenance dose takes five months of rising cost before it flattens, for a first-year total near 5,700 dollars if a protocol reaches and holds the top dose. ^[1]
Not every protocol targets 15 mg. SURMOUNT-1 evaluated three maintenance doses, 5 mg, 10 mg, and 15 mg, so the real ongoing monthly cost depends on which target a protocol settles at. ^[1]
Reconstitution water and needles add a modest, mostly fixed amount on top of the vial cost, and insurance (when it applies) is the one variable that can undercut every figure here.

Most tirzepatide cost searches assume a single number exists, and it does not. What a protocol spends in month one, when the dose is a fraction of the eventual target, looks nothing like what it spends by month five, once the dose has climbed most of the way up the titration schedule. Treating tirzepatide as a flat monthly line item is the most common reason a budget estimate ends up wrong.

This guide builds the month-by-month cost, using this site's own research-compound catalog price and the published SURMOUNT-1 titration schedule, then totals what a full protocol costs over time. It is written for research and educational purposes. Nothing here is a personal dosing recommendation, and none of it instructs anyone to self-administer a research compound. For a route-by-route ranking of cost per milligram across insurance, LillyDirect, and the research market, see how to get tirzepatide cheaper.

Tirzepatide's monthly cost at a glance

Tirzepatide monthly cost by titration step (research-compound market)

Titration step	Weekly dose	Monthly mg consumed	Monthly cost
1	2.5 mg	10 mg	About 100 dollars
2	5 mg	20 mg	About 200 dollars
3	7.5 mg	30 mg	About 300 dollars
4	10 mg	40 mg	About 400 dollars
5	12.5 mg	50 mg	About 500 dollars
6 (maintenance)	15 mg	60 mg	About 600 dollars

That table is the entire shape of a tirzepatide budget: monthly cost climbs in a straight line with the dose, because the underlying arithmetic is simple, monthly milligrams consumed multiplied by this site's per-milligram catalog rate. ^[1]

How much does tirzepatide cost per month?

At this site's catalog price, a single 10 mg vial of research-grade tirzepatide costs 100 dollars, which works out to 10 dollars per milligram. A once-weekly protocol consumes dose times four milligrams a month, so multiplying that by 10 dollars gives the monthly figure at any point in the schedule. At the 2.5 mg starting dose that is 10 milligrams a month, about 100 dollars. At the 15 mg top dose it is 60 milligrams a month, about 600 dollars, six times the starting cost for six times the milligrams.

That six-fold spread is the reason a single "tirzepatide costs X a month" answer is misleading. The honest answer names the step in the schedule, not just the compound.

I priced out a tirzepatide protocol before starting, and I made the mistake almost everyone makes: I looked up the top-dose monthly figure and budgeted for that from day one. It took building an actual month-by-month spreadsheet to realize the first month cost a sixth of what I'd budgeted for.

That changed how I planned the whole thing. Instead of setting aside 600 dollars starting in week one, I matched the monthly line item to the actual step, 100 dollars in month one, climbing every four weeks after that. The cash freed up in the early months went toward the reconstitution supplies and a proper cold-storage routine instead of sitting unused.

The other surprise was how long the climb takes. Five months passed before I hit the top of the schedule, and the total spent getting there was well over a thousand dollars before the maintenance-level monthly cost even started. Budgeting for the ramp, not just the destination, was the part nobody's sticker-price answer had prepared me for.

— Owen Whitfield, Nashville, TN

How the titration schedule changes your monthly cost

The SURMOUNT-1 trial and the resulting labeled schedule escalate tirzepatide's dose in fixed four-week steps, from a 2.5 mg starting dose up to a 15 mg maximum, and each step holds for roughly a month before the next increase. ^[1] Because the monthly cost tracks milligrams consumed, not a flat subscription price, that same schedule is what produces the rising cost curve above.

Two steps in the schedule, 7.5 mg and 12.5 mg, exist only to smooth the climb between the doses that were actually evaluated as maintenance targets, 5 mg, 10 mg, and 15 mg. ^[1] That matters for budgeting because a protocol does not necessarily have to reach the most expensive step to reach a studied maintenance dose.

What a full 6-month titration actually costs

Adding the six monthly figures together gives the total cost of reaching and briefly holding the top of the schedule.

Cumulative cost through a full titration to 15 mg

Through month	Monthly dose reached	Cumulative cost
1	2.5 mg	About 100 dollars
2	5 mg	About 300 dollars
3	7.5 mg	About 600 dollars
4	10 mg	About 1,000 dollars
5	12.5 mg	About 1,500 dollars
6	15 mg (first maintenance month)	About 2,100 dollars

Extending that same maintenance-month cost, about 600 dollars, across the remaining months of a first year adds roughly 4,200 dollars more, for a first-year total near 5,700 dollars if a protocol reaches and holds the 15 mg dose for the full twelve months. That figure describes the top of the schedule specifically; a protocol that settles at a lower studied maintenance dose costs proportionally less, which the next section works through.

The ongoing cost once you reach a maintenance dose

Not every protocol is built around the 15 mg ceiling. SURMOUNT-1 evaluated three maintenance targets, and each one carries a different steady monthly cost once the titration ramp is behind it.

Ongoing monthly cost by maintenance target

Maintenance dose	Monthly mg consumed	Ongoing monthly cost
5 mg	20 mg	About 200 dollars
10 mg	40 mg	About 400 dollars
15 mg	60 mg	About 600 dollars

The gap between the lowest and highest studied maintenance target is a factor of three, not a rounding difference, so which target a protocol is built around matters as much to the ongoing budget as any question of where the compound is sourced. This is reported trial information, not a recommendation for which dose to pursue; that determination sits with the protocol design, not this guide.

Budgeting for reconstitution supplies

The vial is the largest line item, but it is not the only recurring cost. Tirzepatide ships as a lyophilized powder and has to be reconstituted before use, which means water and injection supplies are a standing part of the monthly budget regardless of which titration step a protocol is on.

A single 10 mL bottle of bacteriostatic water reconstitutes several vials at a reasonable concentration, so it stays a modest, largely fixed add-on, roughly 20 to 40 dollars a month, rather than scaling directly with the dose the way the vial cost does.

Common budgeting mistakes

Budgeting for the top-dose monthly cost from day one, which overstates spend for the first several months of a titration protocol that has not reached that step yet.
Ignoring supplies entirely and comparing only vial prices, which understates the real monthly total by the cost of water and needles.
Running out of sterile needles mid-protocol and improvising, which is a quiet way to compromise an otherwise well-budgeted plan; a 10-pack of sterile needles covers roughly two months of once-weekly injections and is worth restocking before it runs out, not after.
Assuming the monthly cost is flat across an entire year, when in fact five of the first six months carry a different figure than the sixth.
Comparing a single vial's sticker price against a competitor's flat monthly program price without converting both to the same unit, which is the mistake how to get tirzepatide cheaper works through in full.

How tirzepatide's monthly cost compares to semaglutide

Because tirzepatide and semaglutide are dosed on different schedules, comparing their monthly research-market cost is not as simple as comparing price per milligram alone. At this site's catalog pricing, tirzepatide runs about 10 dollars per milligram, while research-grade semaglutide runs about 15 dollars per milligram, a higher per-milligram rate. But semaglutide's studied weight-management maintenance dose is far lower, 2.4 mg once weekly, or about 9.6 mg a month, versus tirzepatide's highest studied maintenance dose of 15 mg weekly, about 60 mg a month. ^[2] Multiplying each out, semaglutide's maintenance-dose monthly cost lands lower than tirzepatide's top maintenance tier, around 150 dollars against about 600 dollars, even though tirzepatide is cheaper per milligram. The lower required dose, not the per-milligram price, is what decides the comparison.

Is insurance the biggest lever on monthly cost

Everything above describes the research-compound market specifically. Prescription tirzepatide, billed through insurance, can undercut every figure in this guide when a plan covers it, sometimes to a copay of a few dollars a month, though coverage depends heavily on the specific plan and tends to be broader for the diabetes indication than for the obesity indication. Where insurance does not apply, the full route-by-route comparison, including Eli Lilly's LillyDirect self-pay tiers and their own dose-dependent cost curve, is worked out in how to get tirzepatide cheaper; the three legal access lanes behind those numbers are covered in how to get tirzepatide in the US.

Frequently asked questions

How much does tirzepatide cost per month?: It depends entirely on where a protocol sits in the titration schedule. In the research-compound market, at this site's own 10 mg vial price of 100 dollars, the monthly cost runs from about 100 dollars at the 2.5 mg starting dose to about 600 dollars at the 15 mg top dose, since more milligrams are consumed at each higher step.
Does the monthly cost stay the same throughout a protocol?: No. SURMOUNT-1's titration schedule escalates the dose roughly every four weeks, from 2.5 mg up to 15 mg, and each step consumes more milligrams per month than the last, so the monthly cost rises in the same six steps rather than staying flat.
How much does a full titration to the top dose cost in total?: Working through all six steps at this site's catalog price, the first five escalation months total about 1,500 dollars, and each month at the 15 mg maintenance dose after that adds about 600 dollars, for a first-year total near 5,700 dollars if a protocol reaches and holds the top dose.
Are there monthly costs beyond the vial itself?: Yes. Reconstitution water and injection supplies add a modest, largely fixed amount on top of the vial cost, since a single bottle of bacteriostatic water reconstitutes several vials and a pack of sterile needles covers roughly two months of once-weekly injections.
Is tirzepatide's monthly cost lower with insurance?: It can be dramatically lower when a plan covers it, sometimes a copay of a few dollars, but coverage is plan-specific and not guaranteed, especially for the obesity indication. The full route-by-route cost ranking, including LillyDirect's self-pay tiers, is in how to get tirzepatide cheaper.

Glossary

Titration schedule: The fixed sequence of dose increases, held for a set period at each step, used to build up to a maintenance dose gradually.
Maintenance dose: The dose level a protocol holds at once the titration schedule ends, as opposed to the intermediate steps used only to reach it.
Cost per milligram: Total price divided by total milligrams delivered, the unit that makes different vial sizes and dosing schedules comparable.
Research use only (RUO): Material supplied for laboratory or in-vitro study, explicitly not intended, tested, or approved for human use.
Bacteriostatic water: Sterile water containing a preservative, used to reconstitute lyophilized peptide powder into an injectable solution.

References

Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002.

For research and educational purposes only. Not medical advice. Cost figures reflect this site's own catalog price as of the publish date and can change; the titration schedule described here is reported trial and labeling information, not a personal dosing instruction, and nothing here instructs anyone to self-administer a research compound or to circumvent a prescription requirement. Tirzepatide is FDA approved under the brand names Mounjaro and Zepbound; the research-compound version discussed here for cost purposes is not approved for human use.